Sonoma Pharmaceuticals, Inc. (SNOA) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Sonoma Pharmaceuticals, Inc., with annual and quarterly history.
| Metric | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | -1.13x | -0.79x | -0.58x | -1.29x | -4.18x | -7.51x |
| P/B Ratio | 1.16x | 0.62x | 0.45x | 0.83x | 2.45x | 5.53x |
| P/S Ratio | 0.18x | 0.19x | 0.22x | 0.50x | 1.68x | 1.59x |
| Profitability | ||||||
| Gross Margin | 38.0% | 38.2% | 37.3% | 33.7% | 31.6% | 35.2% |
| Operating Margin | -12.6% | -26.0% | -36.9% | -34.4% | -46.6% | -18.5% |
| Net Margin | -16.3% | -24.2% | -38.0% | -38.8% | -40.3% | -21.2% |
| EBITDA Margin | -12.6% | -25.0% | -35.5% | -33.5% | -45.1% | -17.3% |
| Liquidity | ||||||
| Current Ratio | 2.50x | 3.09x | 3.37x | 3.71x | 2.82x | 3.18x |
| Quick Ratio | 1.75x | 2.38x | 2.64x | 2.94x | 2.37x | 2.56x |
| Leverage | ||||||
| Debt/Equity | 0.27x | 0.07x | 0.10x | 0.11x | 0.16x | 0.50x |
YoY = year-over-year change. Source: FMP..